Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jan 22;25(1):33.
doi: 10.1186/s13054-021-03470-3.

Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients

Geoffroy Hariri  1   2 , Tomas Urbina  1   2 , Sandie Mazerand  1 , Naike Bige  1 , Jean-Luc Baudel  1 , Hafid Ait-Oufella  3   4   5
Affiliations
Observational Study

Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients

Geoffroy Hariri et al. Crit Care. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests. H.A.O. declares having received fees for medical trainings from the laboratories AMOMED.

Figures

Fig. 1
Fig. 1
Heart rate (Red) and Landiolol dosage (blue) changes during the first 24 h of Landiolol infusion
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Steinberg I, Brogi E, Pratali L, Trunfio D, Giuliano G, Bignami E, Forfori F. Atrial fibrillation in patients with septic shock: a one-year observational pilot study. Turk J Anaesthesiol Reanim. 2019;47(3):213–219. doi: 10.5152/TJAR.2019.44789. - DOI - PMC - PubMed
    1. Meierhenrich R, Steinhilber E, Eggermann C, Weiss M, Voglic S, Bogelein D, Gauss A, et al. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care. 2010;14(3):R108. doi: 10.1186/cc9057. - DOI - PMC - PubMed
    1. Schmittinger CA, Torgersen C, Luckner G, Schroder DC, Lorenz I, Dunser MW. Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med. 2012;38(6):950–958. doi: 10.1007/s00134-012-2531-2. - DOI - PubMed
    1. Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth. 2001;48(10):985–989. doi: 10.1007/BF03016588. - DOI - PubMed
    1. Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, Yamada Y, et al. Efficacy and safety of landiolol, an ultra-short-acting beta1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. Lancet Respir Med. 2020;9:863–872. doi: 10.1016/S2213-2600(20)30037-0. - DOI - PubMed

Publication types